Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer

نویسندگان

  • Magali Michaut
  • Suet-Feung Chin
  • Ian Majewski
  • Tesa M. Severson
  • Tycho Bismeijer
  • Leanne de Koning
  • Justine K. Peeters
  • Philip C. Schouten
  • Oscar M. Rueda
  • Astrid J. Bosma
  • Finbarr Tarrant
  • Yue Fan
  • Beilei He
  • Zheng Xue
  • Lorenza Mittempergher
  • Roelof J.C. Kluin
  • Jeroen Heijmans
  • Mireille Snel
  • Bernard Pereira
  • Andreas Schlicker
  • Elena Provenzano
  • Hamid Raza Ali
  • Alexander Gaber
  • Gillian O’Hurley
  • Sophie Lehn
  • Jettie J.F. Muris
  • Jelle Wesseling
  • Elaine Kay
  • Stephen John Sammut
  • Helen A. Bardwell
  • Aurélie S. Barbet
  • Floriane Bard
  • Caroline Lecerf
  • Darran P. O’Connor
  • Daniël J. Vis
  • Cyril H. Benes
  • Ultan McDermott
  • Mathew J. Garnett
  • Iris M. Simon
  • Karin Jirström
  • Thierry Dubois
  • Sabine C. Linn
  • William M. Gallagher
  • Lodewyk F.A. Wessels
  • Carlos Caldas
  • Rene Bernards
چکیده

Invasive lobular carcinoma (ILC) is the second most frequently occurring histological breast cancer subtype after invasive ductal carcinoma (IDC), accounting for around 10% of all breast cancers. The molecular processes that drive the development of ILC are still largely unknown. We have performed a comprehensive genomic, transcriptomic and proteomic analysis of a large ILC patient cohort and present here an integrated molecular portrait of ILC. Mutations in CDH1 and in the PI3K pathway are the most frequent molecular alterations in ILC. We identified two main subtypes of ILCs: (i) an immune related subtype with mRNA up-regulation of PD-L1, PD-1 and CTLA-4 and greater sensitivity to DNA-damaging agents in representative cell line models; (ii) a hormone related subtype, associated with Epithelial to Mesenchymal Transition (EMT), and gain of chromosomes 1q and 8q and loss of chromosome 11q. Using the somatic mutation rate and eIF4B protein level, we identified three groups with different clinical outcomes, including a group with extremely good prognosis. We provide a comprehensive overview of the molecular alterations driving ILC and have explored links with therapy response. This molecular characterization may help to tailor treatment of ILC through the application of specific targeted, chemo- and/or immune-therapies.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Mammographic findings in different breast cancer subtypes (luminal, Her2 positive, triple negative)

Background: Prognosis and management of breast cancer are defined by different variables including histological type, grading, clinical stage, Her2+, estrogen and progesterone receptor conditions. Generally, mammography is one of the most important imaging which is done in breast cancer patients. The aim of this research was to evaluate different mammographic patterns in different breast cancer...

متن کامل

Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast

Papillary carcinoma (PC) is a rare type of breast cancer, which comprises three histologic subtypes: encapsulated PC (EPC), solid PC (SPC) and invasive PC (IPC). Microarray-based gene expression and Affymetrix SNP 6.0 gene copy number profiling, and RNA-sequencing revealed that PCs are luminal breast cancers that display transcriptomic profiles distinct from those of grade- and estrogen recepto...

متن کامل

Is “Basal-like” Carcinoma of the Breast a Distinct Clinicopathologic Entity? A Critical Review with Cautionary Notes

This review deals with studies that have used cDNA microarrays and immunohistochemistry to identify a subtype of breast carcinoma recently known as “basal-like” carcinoma. The key breast carcinoma studies are critically discussed to highlight methodological problems in cohort selection, definitions, interpretation of results, an...

متن کامل

Genetic alterations in lobular breast cancer by comparative genomic hybridization.

Infiltrating lobular carcinoma (ILC) and infiltrating ductal carcinoma (IDC) are distinguished by their histopathological appearance. However, little is known about the differences in genetic changes between lobular cancers and ductal cancers. We used comparative genomic hybridization (CGH) and compared aberrations in 19 ILCs and 46 IDCs. The total number of aberrations was lower in ILC than in...

متن کامل

Patterns of chromosomal alterations in breast ductal carcinoma in situ.

PURPOSE Ductal carcinoma in situ (DCIS) is thought to be a nonobligate precursor of invasive cancer. Genomic changes specific to pure DCIS versus invasive cancer, as well as alterations unique to individual DCIS subtypes, have not been fully defined. EXPERIMENTAL DESIGN Chromosomal copy number alterations were examined by comparative genomic hybridization in 34 cases of pure DCIS and compared...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 6  شماره 

صفحات  -

تاریخ انتشار 2016